ロード中...
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How
In an era of Precision Medicine, it is vital to collect biological data within clinical trials and to integrate their analysis within the outcomes of the trial. The identification of genomic biomarkers that affect treatment response to smoking cessation treatment, both pharmacological and behavioral...
保存先:
| 出版年: | Nicotine Tob Res |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896450/ https://ncbi.nlm.nih.gov/pubmed/28498934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntx097 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|